By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antiadrenergic agents (central) with thiazides > Hydrochlorothiazide and methyldopa > Hydrochlorothiazide and methyldopa Side Effects
Antiadrenergic agents (central) with thiazides

Hydrochlorothiazide / methyldopa Side Effects

Summary

Commonly reported side effects of hydrochlorothiazide/methyldopa include: positive direct coombs test. Continue reading for a comprehensive list of adverse effects.

Applies to hydrochlorothiazide / methyldopa: oral tablet.

Serious side effects

Along with its needed effects, hydrochlorothiazide/methyldopa may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking hydrochlorothiazide / methyldopa:

Rare

  • Unexplained fever shortly after starting to take this medicine

Check with your doctor as soon as possible if any of the following side effects occur while taking hydrochlorothiazide / methyldopa:

Signs and symptoms of too much potassium loss

  • Dry mouth
  • increased thirst
  • irregular heartbeats
  • muscle cramps or pain
  • nausea or vomiting
  • unusual tiredness or weakness
  • weak pulse

Less common

  • Mental depression or anxiety
  • nightmares or unusually vivid dreams

Rare

  • Cough or hoarseness
  • dark or amber urine
  • diarrhea or stomach cramps (severe or continuing)
  • fever, chills, troubled breathing, and fast heartbeat
  • general feeling of discomfort or illness or weakness
  • joint pain
  • lower back or side pain
  • painful or difficult urination
  • pale stools
  • skin rash, hives, or itching
  • stomach pain (severe) with nausea and vomiting
  • tiredness or weakness after having taken this medicine for several weeks (continuing)
  • yellow eyes or skin

Other side effects

Some side effects of hydrochlorothiazide / methyldopa may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Dizziness or light-headedness when getting up from a lying or sitting position
  • drowsiness
  • dryness of mouth
  • headache

Less common

  • Decreased sexual ability or interest in sex
  • diarrhea
  • increased sensitivity of skin to sunlight (skin rash, itching, redness or other discoloration of skin or severe sunburn after exposure to sunlight)
  • loss of appetite
  • numbness, tingling, pain, or weakness in hands or feet
  • slow heartbeat
  • stuffy nose
  • swelling of breasts or unusual milk production

For Healthcare Professionals

Applies to hydrochlorothiazide / methyldopa: oral tablet.

Cardiovascular

Hydrochlorothiazide:

Frequency not reported: Hypotension, orthostatic hypotension, necrotizing angiitis, vasculitis

Methyldopa:

Frequency not reported: Angina pectoris aggravated, congestive heart failure, prolonged carotid sinus hypersensitivity, orthostatic hypotension, bradycardia, myocarditis, pericarditis, vasculitis[Ref]

Dermatologic

Hydrochlorothiazide:

Frequency not reported: Cutaneous vasculitis, photosensitivity, urticaria, rash, purpura, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, alopecia

Methyldopa:

Frequency not reported: Toxic epidermal necrolysis, rash[Ref]

Gastrointestinal

Hydrochlorothiazide:

Frequency not reported: Pancreatitis, diarrhea, vomiting, sialadenitis, cramping, constipation, gastric irritation, nausea

Methyldopa:

Frequency not reported: Pancreatitis, colitis, vomiting, diarrhea, sialadenitis, sore tongue, black tongue, nausea, constipation, distention, flatus, dry mouth[Ref]

Hematologic

Hydrochlorothiazide:

Frequency not reported: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia

Methyldopa:

Frequency not reported: Bone marrow depression, leukopenia, granulocytopenia, thrombocytopenia, hemolytic anemia, Coombs test positive, eosinophilia[Ref]

Nervous system

Hydrochlorothiazide:

Frequency not reported: Vertigo, paresthesias, dizziness, headache

Methyldopa:

Frequency not reported: Sedation, headache, Parkinsonism, Bell's palsy, mental acuity decreased, involuntary choreoathetotic movements, cerebrovascular insufficiency symptoms, dizziness, lightheadedness, paresthesias[Ref]

Hepatic

Hydrochlorothiazide:

Frequency not reported: Intrahepatic cholestatic jaundice

Methyldopa:

Frequency not reported: Liver disorders, hepatitis, jaundice, liver function tests abnormal[Ref]

Other

Hydrochlorothiazide:

Frequency not reported: Weakness, fever

Methyldopa:

Frequency not reported: Asthenia, weakness, edema, drug-related fever, breast enlargement, gynecomastia, lactation[Ref]

Psychiatric

Hydrochlorothiazide:

Frequency not reported: Restlessness

Methyldopa:

Frequency not reported: Psychic disturbances, nightmares, reversible mild psychoses, depression, libido decreased[Ref]

Genitourinary

Hydrochlorothiazide:

Frequency not reported: Glycosuria, impotence

Methyldopa:

Frequency not reported: Amenorrhea, impotence[Ref]

Immunologic

Hydrochlorothiazide:

Frequency not reported: Anaphylactic reactions

Methyldopa:

Frequency not reported: Antinuclear antibody test positive, LE cells, rheumatoid factor[Ref]

Metabolic

Hydrochlorothiazide:

Frequency not reported: Anorexia, electrolyte imbalance, hyperglycemia, hyperuricemia

Methyldopa:

Frequency not reported: Weight gain[Ref]

Musculoskeletal

Hydrochlorothiazide:

Frequency not reported: Muscle spasm

Methyldopa:

Frequency not reported: Lupus-like syndrome, arthralgia, myalgia[Ref]

Renal

Hydrochlorothiazide:

Frequency not reported: Renal failure, renal dysfunction, interstitial nephritis

Methyldopa:

Frequency not reported: BUN increased[Ref]

Respiratory

Hydrochlorothiazide:

Frequency not reported: Respiratory distress, pneumonitis, pulmonary edema

Methyldopa:

Frequency not reported: Nasal stuffiness[Ref]

Endocrine

Methyldopa:

Frequency not reported: Hyperprolactinemia[Ref]

Ocular

Hydrochlorothiazide:

Frequency not reported: Transient blurred vision, xanthopsia[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by